Recurrent cervical cancer treated with cisplatin and methotrexate.
AffiliationChristie Hospital NHS Trust, Withington, Manchester, UK.
MetadataShow full item record
AbstractA combination of cisplatin (80 mg/m2) and methotrexate (200 mg bolus and 400 mg as a 12-hour infusion) was given to 40 patients who developed local recurrence of cervical cancer after radiotherapy. A maximum of six courses was given at monthly intervals. Twenty-five of the forty (63%) evaluable patients responded, of which 4 (10%) responded completely. A symptomatic response, with reduction of pain, leg oedema, vaginal discharge and breathlessness was seen in 27 (68%) of patients. The median survival of all patients was 11 months. Toxicity was moderate; WHO grade 1 or greater was observed in 83% for nausea and vomiting, 67% for myelosuppression and 47% for mucositis. This combination chemotherapy is active in the treatment of recurrent cervical cancer and a modification of this regimen is currently being assessed as neo-adjuvant therapy in patients with Stage IIB-IVA cervical cancer.
CitationRecurrent cervical cancer treated with cisplatin and methotrexate. 1993, 5 (4):203-6 Clin Oncol
- Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
- Authors: McCaffrey R, Bahtiyar M, Kohorn EI, Chambers JT, Schwartz PE, Chambers SK
- Issue date: 2011 Apr
- Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
- Authors: Zanaboni F, Grijuela B, Giudici S, Cormio G, Babilonti L, Ghezzi F, Giorda G, Scambia G, Franchi M, Lorusso M, Ditto A, Lorusso D, Raspagliesi F
- Issue date: 2013 Mar
- The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer.
- Authors: Symonds RP, Habeshaw T, Reed NS, Paul J, Pyper E, Yosef H, Davis J, Hunter R, Davidson SE, Stewart A, Cowie V, Sarkar T
- Issue date: 2000 May
- Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
- Authors: Adachi S, Ogasawara T, Tsubamoto H, Oku H, Hori Y, Tsuji Y, Takemura T, Koyama K
- Issue date: 2001
- [Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer: study of 46 patients].
- Authors: Wang CY, Ma D, Zhu T, Chen SY, Zhang QH, Song XJ, Chen TH, Gu MJ
- Issue date: 2005 Aug 10